NCT07279597 2025-12-19A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder CancerTongji HospitalPhase 2 Not yet recruiting45 enrolled